ArticleAntibiotics (Basel, Switzerland)2023
RETRACTED: Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward.
Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed.
- Antimicrobial Resistance as a Global Public Health Challenge: Epidemiological Burden, Bioethical Dimensions and Emerging Therapeutic Strategies.Infectious disease reports · 2026Review
- Beyond new pills: integrative strategies to overcome multidrug-resistant bacteria.Archives of microbiology · 2026Review
- Significant gaps in practice present despite higher levels of public awareness in antibiotic use and antimicrobial resistance in the western province of Sri Lanka.Access microbiology · 2026Article
- Using GIS Dashboards to highlight AMR data disparities in Africa for Policy, Research, and Public Health.PloS one · 2026Article
- Article
- Adapting global guidelines to local contexts: optimising community-acquired pneumonia (CAP) specific prescribing in Pakistan to counter antimicrobial resistance.BMJ open respiratory research · 2025Article
- Analysis of Clinical Gram-Negative Carbapenem Resistant Acinetobacter baumannii and Klebsiella pneumoniae Isolates from Wounds of Patients at a Hospital Reveals Complex Resistome and the First Report of blaCurrent microbiology · 2025Article
- Toxic threats from plastic waste: human health impacts, challenges, and policy solutions.RSC advances · 2025Review
- RETRACTED: Kanan et al. Empowering Low- and Middle-Income Countries to Combat AMR by Minimal Use of Antibiotics: A Way Forward.Antibiotics (Basel, Switzerland) · 2025Article
- Human and Veterinary Medicine Collaboration: Synergistic Approach to Address Antimicrobial Resistance Through the Lens of Planetary Health.Antibiotics (Basel, Switzerland) · 2025Review
- Behavioral and Socio-Economic Determinants of Antimicrobial Resistance in Sub-Saharan Africa: A Systematic Review.Infection and drug resistance · 2025Review
- Ethiopian antimicrobial consumption trends in human health sector: A surveillance report 2020-2022.PloS one · 2025Article
- Antibiotic Use in Livestock and Environmental Antibiotic Resistance: A Narrative Review.Environmental health insights · 2025Review
- Bacterial agents and antibiotic resistance in febrile neutropaenia in Africa: A systematic review and meta-analysis.African journal of laboratory medicine · 2025Review
- Antibiotic prescribing patterns at outpatient clinics in Western and Coastal Kenya.PLOS global public health · 2025Article
- Epidemiological and Clinical Characteristics of Pediatric Acute Drug Intoxications: A Retrospective Analysis.Children (Basel, Switzerland) · 2024Article
- Article
- Differences in Patient Access to Newly Approved Antibacterial Drugs in EU/EEA Countries.Antibiotics (Basel, Switzerland) · 2024Review
- Update on antimicrobial resistance in Somalia: Current status, challenges, opportunities, and future perspectives.Heliyon · 2024Review
- Evaluation of Surveillance Strategies of Antimicrobial Consumption in Animals.Antibiotics (Basel, Switzerland) · 2024Review
Corrections and comments
- Retraction · 2025-01-14Concerns/Issues about Authorship/Affiliation · Concerns/Issues about Referencing/Attributions ·
- Retracted
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic overuse poses a critical global health concern, especially in low- and middle-income countries (LMICs) where access to quality healthcare and effective regulatory frameworks often fall short. This issue necessitates a thorough examination of the factors contributing to antibiotic overuse in LMICs, including weak healthcare infrastructure, limited access to quality services, and deficiencies in diagnostic capabilities. To address these challenges, regulatory frameworks should be implemented to restrict non-prescription sales, and accessible point-of-care diagnostic tools must be emphasized. Furthermore, the establishment of effective stewardship programs, the expanded use of vaccines, and the promotion of health systems, hygiene, and sanitation are all crucial components in combating antibiotic overuse. A comprehensive approach that involves collaboration among healthcare professionals, policymakers, researchers, and educators is essential for success. Improving healthcare infrastructure, enhancing access to quality services, and strengthening diagnostic capabilities are paramount. Equally important are education and awareness initiatives to promote responsible antibiotic use, the implementation of regulatory measures, the wider utilization of vaccines, and international cooperation to tackle the challenges of antibiotic overuse in LMICs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.